Should we be integrating tumor treating fields into standard glioblastoma treatment?

The EF14 trial preliminary results were just published in JAMA and demonstrate an improvement in both PFS and OS for the experimental arm, and the device has received FDA approval. In the neuro-oncology community, there is still anticipation regarding the final results (the entire cohort outcome dat...